17 devices · GMDN 57543
These in vitro diagnostic devices consist of antibody cocktails designed to identify multiple biological markers linked to prostate cancer within clinical specimens. By detecting specific proteins or cellular indicators, they assist pathologists in evaluating tissue samples for signs of malignancy or prostatic intraepithelial neoplasia.
These products are supplied as specialized reagents intended for laboratory use in the qualitative or quantitative analysis of patient samples. Users should note that these diagnostic tools are designed to target specific antigenic determinants to support clinical assessment of prostate health.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.